probenecid has been researched along with rifamycins in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kenwright, S; Levi, AJ | 1 |
| Courtois, A; Fardel, O; Guillouzo, A; Lagadic, D; Payen, L | 1 |
| PLATTNER, HC; SCHERER, J | 1 |
3 other study(ies) available for probenecid and rifamycins
| Article | Year |
|---|---|
Impairment of hepatic uptake of rifamycin antibiotics by probenecid, and its therapeutic implications.
Topics: Administration, Oral; Animals; Bilirubin; Costs and Cost Analysis; Drug Synergism; Drug Therapy, Combination; Health Expenditures; Humans; In Vitro Techniques; Liver; Liver Function Tests; Male; Probenecid; Rats; Rifamycins; Sulfobromophthalein; Tuberculosis, Pulmonary | 1973 |
Evidence for a multidrug resistance-associated protein 1 (MRP1)-related transport system in cultured rat liver biliary epithelial cells.
Topics: Animals; Animals, Newborn; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Bile Ducts, Intrahepatic; Biological Transport; Blotting, Northern; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Epithelial Cells; Fluoresceins; Indomethacin; Indoprofen; Multidrug Resistance-Associated Proteins; Probenecid; Rats; Rats, Sprague-Dawley; Rifamycins; RNA; Tumor Cells, Cultured | 1999 |
[PRESENT STATUS OF THE TREATMENT OF STAPHYLOCOCCAL DISEASES].
Topics: Anti-Bacterial Agents; Cross Infection; Drug Therapy; Humans; Methicillin; Oxacillin; Penicillin G; Penicillins; Probenecid; Rifamycins; Staphylococcal Infections; Vancomycin | 1965 |